Overview

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Use of Muscle relaxant and reversal with Sugammadex at end of airway procedures will reduce the time to extubation after end of procedure
Phase:
Phase 4
Details
Lead Sponsor:
West Virginia University
Treatments:
Glycopyrrolate
Neostigmine